期刊
GENE THERAPY
卷 11, 期 6, 页码 552-559出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.gt.3302181
关键词
adenovirus; ovarian neoplasms; virus replication, biological therapy
类别
资金
- NCI NIH HHS [R01 CA93796, R01 CA94084, R01 CA83821, P50 CA83591] Funding Source: Medline
Conditionally replicating adenoviruses (CRADs) take advantage of tumor-specific characteristics for preferential replication and subsequent oncolysis of cancer cells. The antitumor effect is determined by the capability to infect tumor cells. Here, we used RGDCRADcox-2R, which features the cyclooxygenase-2 promoter for replication control and an integrin binding RGD-4C motif for enhanced infectivity of ovarian cancer cells. RGDCRADcox-2R replicated in and killed human ovarian cancer cells effectively, while the replication in nonmalignant cells was low. Importantly, the therapeutic efficacy, as evaluated in an orthotopic model of peritoneally disseminated ovarian cancer, was significantly improved and toxicity was lower than with a wild-type virus. Thus, this CRAD could be tested for treatment of ovarian cancer in humans.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据